The global Diabetic Retinopathy Market size was estimated at USD USD 6.24 Bn in 2021, growing at a CAGR of 6.9% during the forecast period 2021-2027. Report Snapshot of Diabetic Retinopathy Market: Diabetic retinopathy is the most common form of diabetic eye disease. Diabetic retinopathy usually affects the people with diabetes from number of years. High glucose levels in the cause damage to the retinal blood vessels is the main manifestation in diabetic retinopathy. In some other cases, the retinal blood vessels will be swollen (macular oedema) with a fluid leaking into rear of eye. In few cases, on the surface of the retinal blood vessels will grow abnormally. If diabetic retinopathy market is not properly treated, can progressively become more serious and seriously affects vision which may leads to blindness. Diabetic retinopathy can be treated by various methods depending on the stage of disease. Diabetic retinopathy is one of the major causes of blindness in adult population in America. As per, World Health Organisation (WHO), 347 Mn people were suffering from diabetes globally in 2012, in which 11% population are having diabetic retinopathy. Increase in focus on Asia-pacific and LAMEA regions by various vendors is expected to boost growth of the market According to the World Bank, in 2015,10.4% of rate of  prevalence of diabetes was observed in Brazil. Strategic acquisitions, geographic expansion, agreements, partnerships and new product launches are the most vital strategic implementations by most of the companies in the market of diabetic retinopathy.


Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084


Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX